The pharmaceutical industry is no longer only about discovering molecules and testing medicines.
Today, every stage of drug development creates massive amounts of laboratory data; from early research, clinical trials, quality testing, manufacturing, and regulatory submissions.
Large biopharma companies such as Pfizer, Roche, Novartis, Merck, AstraZeneca, and Johnson & Johnson operate thousands of laboratory processes across multiple countries.
Managing this complexity manually is becoming impossible.
This is why Laboratory Information Management Systems (LIMS) have become one of the most important digital transformation technologies in life sciences.
A modern LIMS helps companies collect, organize, track, analyze, and secure laboratory information in one connected environment.
Why LIMS has become critical for large biopharma companies in 2025
Drug development has become more complex than ever.
Companies are moving beyond traditional small-molecule drugs and investing heavily in:
- Cell and gene therapies
- Biologics
- mRNA medicines
- Personalized medicine
- Advanced diagnostic platforms
These therapies require extremely accurate sample tracking because one mistake in sample identity, storage condition, or testing data can impact the entire development process.
According to industry analysis, global biopharma R&D investment reached around $102 billion in 2024, showing continued growth in innovation spending.
Clinical trial activity also returned to pre-pandemic levels, with approximately 5,318 clinical trial starts in 2024, almost matching the 5,316 trials recorded in 2019.
More research programs mean more laboratory data.
More laboratory data means stronger digital infrastructure is required.
The biggest problem: laboratory data is growing faster than traditional systems
A modern pharmaceutical company may manage:
- Millions of biological samples
- Thousands of laboratory instruments
- Multiple research locations
- Global quality testing operations
- Regulatory documentation
From country-level data to competitor intelligence and in-depth market segments, our experts deliver FREE customized sample reports; Download Now: https://www.towardshealthcare.com/download-sample/5012
Earlier, many laboratories depended on spreadsheets, manual documentation, and disconnected databases.
This created challenges:
| Challenge | Business Impact |
|---|---|
| Manual data entry | Higher risk of errors |
| Separate laboratory systems | Difficult collaboration |
| Paper-based records | Slow audits |
| Poor sample tracking | Research delays |
| Limited visibility | Slow decision-making |
A LIMS solves this by creating a single digital record for every laboratory activity.
How LIMS supports digital transformation in biopharma
1. Better sample management
In biopharma, samples are extremely valuable.
A single research project may involve thousands of biological samples collected over months or years.
LIMS tracks:
- Sample location
- Storage conditions
- Testing history
- Responsible scientist
- Data generated from analysis
This reduces the risk of losing critical research information.
For cell and gene therapy companies, this becomes even more important because patient-derived materials require strict chain-of-custody tracking.
2. Faster research and development decisions
Drug development is a long and expensive process.
On average, bringing a new medicine from discovery to market can take more than 10 years, with billions of dollars invested across research, clinical trials, and regulatory approval.
Because of this, companies are focusing on improving laboratory efficiency.
A connected LIMS allows scientists to access accurate information faster.
Instead of spending hours searching through different systems, teams can immediately review:
- Test results
- Historical experiments
- Quality information
- Sample performance
This helps researchers make faster decisions.
3. Supporting regulatory compliance
Pharmaceutical companies operate under strict regulatory requirements.
Organizations must maintain:
- Accurate electronic records
- Data integrity
- Audit trails
- Controlled access
The U.S. FDA’s electronic records requirements under 21 CFR Part 11 focus on ensuring electronic records and signatures are trustworthy, reliable, and equivalent to paper records.
Modern LIMS platforms help companies meet these requirements by automatically recording:
- Who changed information
- When changes happened
- What was modified
4. Connecting laboratories with automation
The future laboratory is becoming highly automated.
A modern biopharma laboratory may include:
- Robotic systems
- Automated testing instruments
- Analytical platforms
- Digital monitoring systems
LIMS connects these technologies.
For example:
A sample enters the laboratory →
The instrument performs testing →
Results automatically enter the system →
Quality teams review the data →
Reports are generated digitally.
This reduces manual work and improves consistency.
Top LIMS platforms transforming large biopharma companies in 2025
1. LabWare LIMS — Enterprise laboratory management
LabWare is one of the most recognized LIMS platforms in regulated industries.
Large pharmaceutical companies use it because it supports:
- Global laboratory networks
- Quality control operations
- Manufacturing testing
- Research workflows
Its biggest advantage is scalability.
For multinational companies managing laboratories across continents, a single standardized system improves operational control.
2. Thermo Fisher SampleManager LIMS — Strong focus on pharma manufacturing
Thermo Fisher’s SampleManager LIMS is widely used in life science environments.
It supports:
- Sample lifecycle management
- Laboratory workflows
- Instrument integration
- Quality control processes
It is especially valuable in pharmaceutical manufacturing where every production batch requires detailed testing.
A manufacturing delay can cost companies millions, so accurate laboratory information is essential.
3. LabVantage LIMS — Designed for research-heavy organizations
LabVantage is widely associated with research environments.
It supports areas including:
- Genomics
- Biobanking
- Cell therapy
- Molecular research
As personalized medicine grows, companies require better ways to manage biological data.
4. Sapio Sciences LIMS — Cloud-based laboratory transformation
Cloud adoption is becoming a major trend in laboratory digitalization.
Companies want:
- Faster implementation
- Easier global access
- Lower infrastructure complexity
Cloud-based LIMS allows research teams across different locations to work on connected data environments.
LIMS market growth: why investment is increasing
The laboratory information management system market is expanding because healthcare and life science companies need better control over growing data volumes.
Key growth factors include:
| Market Driver | Impact |
|---|---|
| Growing clinical research | More laboratory data |
| Biologics growth | Higher sample complexity |
| Regulatory pressure | Need for digital records |
| Laboratory automation | Demand for connected systems |
| Cloud adoption | Faster digital transformation |
The future of LIMS: from software system to laboratory intelligence platform
The next generation of LIMS will not only store laboratory information.
It will become a connected platform combining:
- Laboratory automation
- Data analytics
- Cloud infrastructure
- Artificial intelligence tools
- Real-time decision support
Biopharma companies are under pressure to develop medicines faster while maintaining quality and compliance.
As research programs grow and therapies become more complex, LIMS will become a core technology behind the future pharmaceutical laboratory.
For large biopharma companies, selecting the right LIMS is no longer just an IT decision.
It is a strategic decision that impacts research speed, product quality, regulatory success, and long-term competitiveness.
Important Links
Access our exclusive, data-rich dashboard dedicated to the biopharmaceutical industry – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a part of Towards Healthcare Research and Consulting is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium